Research team reports on new treatment option for brain tumors that relapse or fail to respond to standard of care
A methodological leap in the exploration of memory
27 July 2022Intravesical chemotherapy combination provides effective treatment alternative for non-muscle invasive bladder cancer
27 July 2022Research team reports on new treatment option for brain tumors that relapse or fail to respond to standard of care
Taken twice daily, oral olutasidenib helped to stabilize relapsed or refractory gliomas in heavily pretreated patients with less toxicity than standard of care treatment, according to a study led by Sylvester Comprehensive Cancer Center at the University of Miami School of Medicine and published in Neuro-Oncology.
